{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:12:41Z","timestamp":1648606361819},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf01676708","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T10:55:14Z","timestamp":1115808914000},"page":"87-94","source":"Crossref","is-referenced-by-count":5,"title":["Gynaecologic effects of tamoxifen"],"prefix":"10.1007","volume":"12","author":[{"given":"Dennis Yi-Shin","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn D.","family":"Runowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01676708_CR1","volume-title":"Non-Steroidal Antioestrogens","author":"R.L. Sutherland","year":"1981","unstructured":"Sutherland, R.L. and Jordan, VC (1981)Non-Steroidal Antioestrogens. Sidney, Academic Press."},{"key":"BF01676708_CR2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0022-4731(74)90388-4","volume":"5","author":"V.C. Jordan","year":"1974","unstructured":"Jordan, V.C. (1974) Antitumor activity of antiestrogen ICI46, 474 (tamoxifen) in dimethylbenzantracene (DMBA)-induced rat mammary carcinoma model (abstract).J Steroid Biochem. 5, 354.","journal-title":"J Steroid Biochem."},{"key":"BF01676708_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/joe.0.0680297","volume":"68","author":"V.C. Jordan","year":"1976","unstructured":"Jordan, V.C. and Dowse L.J. (1976) Tamoxifen as an antitumour agent: effect on oestrogen binding.J. Endocrinol. 68, 297\u2013303.","journal-title":"J. Endocrinol."},{"key":"BF01676708_CR4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0014-2964(75)90129-2","volume":"11","author":"R.I. Nicholson","year":"1975","unstructured":"Nicholson, R.I. and Golder, M.P. (1975) The effect of synthetic antioestrogens on the growth and biochemistry of rat mammary tumours.Eur. J. Cancer. 11, 571\u201379.","journal-title":"Eur. J. Cancer."},{"key":"BF01676708_CR5","first-page":"1421","volume":"60","author":"M. Lippman","year":"1976","unstructured":"Lippman, M., Bolan, G. and Huff, K. (1976) Interaction of antiestrogen with human breast cancer in long-term tissue culture.Cancer Treat. Rep. 60, 1421\u201329.","journal-title":"Cancer Treat. Rep."},{"key":"BF01676708_CR6","first-page":"6274","volume":"46","author":"A. Gulling","year":"1986","unstructured":"Gulling, A., Barer, G., Dacca, A., Farina, A., Ferret, C., Screpanti, I., Dianzani, M. and Frati, L. (1986) Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.Cancer Res. 46, 6274\u201378.","journal-title":"Cancer Res."},{"key":"BF01676708_CR7","first-page":"2462","volume":"45","author":"C.A O\u2019Brien","year":"1985","unstructured":"O\u2019Brien, C.A, Liskamp, R.M., Solomon, D.H. and Weinstein, I.B. (1985) Inhibition of protein kinase C by tamoxifen.Cancer Res. 45, 2462\u201365.","journal-title":"Cancer Res."},{"key":"BF01676708_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(87)90193-0","volume":"48","author":"C. Knabbe","year":"1987","unstructured":"Knabbe, C., Lippman, M.E., Wakefield, L.M., Flanders, K.C., Kasid, A., Derynck, R., and Dickson R.B. (1987) Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancers.Cell. 48, 417\u201328.","journal-title":"Cell."},{"key":"BF01676708_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-57-2-373","volume":"57","author":"L.C. Murphy","year":"1983","unstructured":"Murphy, L.C., and Sutherland R.L. (1983) Antitumor activity of clomiphene analogs in vitro: Relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. J. Clin.Endocrinol. Metabol. 57, 373\u201379.","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"BF01676708_CR10","first-page":"4517","volume":"47","author":"V.C. Jordan","year":"1987","unstructured":"Jordan, V.C., Fritz, N.F. and Tormey, D.C. (1987) Long-term adjuvant therapy with tamoxifen: Effects on sex hormone binding globulin and antithrombin III.Cancer Res. 47, 4517\u201319.","journal-title":"Cancer Res."},{"key":"BF01676708_CR11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0277-5379(87)90313-0","volume":"23","author":"J. Berry","year":"1987","unstructured":"Berry, J., Green, B.J. and Matheson, D.S. (1987) Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer.Eur. J. Cancer Clin. Oncol. 23, 517\u201320.","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"BF01676708_CR12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/jnci\/82.21.1693","volume":"82","author":"M. Pollak","year":"1990","unstructured":"Pollak, M., Costantino, J., Polychronakos, C., Blauer, S.A., Guyda, H., Redmond, C., Fisher, B. and Margolese R. (1990) Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients.J. Natl. Cancer Inst. 82, 1693\u201397.","journal-title":"J. Natl. Cancer Inst."},{"key":"BF01676708_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0305-7372(78)80017-6","volume":"5","author":"H. Mouridsen","year":"1978","unstructured":"Mouridsen, H., Palshof, T., Patterson, J. and Battersby, L. (1978) Tamoxifen in advanced breat cancer.Cancer Treat. Rev. 5, 131\u201341.","journal-title":"Cancer Treat. Rev."},{"key":"BF01676708_CR14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1971.33","volume":"25","author":"M.P. Cole","year":"1971","unstructured":"Cole, M.P., Jones, C.T.Z. and Todd, I.D.H. (1971) A new antioestrogenic agent in late breast cancer: an early clinical appraisal of ICI46,474.Br. J. Cancer. 25, 270\u201375.","journal-title":"Br. J. Cancer."},{"key":"BF01676708_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.1.5844.13","volume":"i","author":"H.W.C. Ward","year":"1973","unstructured":"Ward, H.W.C. (1973) Antioestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.Br. Med. J. i, 13\u20134.","journal-title":"Br. Med. J."},{"key":"BF01676708_CR16","first-page":"38","volume":"67","author":"M.J. O\u2019Halloran","year":"1974","unstructured":"O\u2019Halloran, M.J. and Maddock, P.G. (1974) ICI46,474 in breast cancer.J. Irish. Med. Assoc. 67, 38\u201339.","journal-title":"J. Irish. Med. Assoc."},{"key":"BF01676708_CR17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","volume":"319","author":"Early breast cancer trialists collaborative group","year":"1988","unstructured":"Early breast cancer trialists collaborative group. (1988) Effect of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer.N. Engl. J. Med. 319, 1681\u201392.","journal-title":"N. Engl. J. Med."},{"key":"BF01676708_CR18","first-page":"171","volume":"2","author":"Breast Cancer Trials Committee, Scottish Cancer Trials Office, (MRC) Edinburgh","year":"1987","unstructured":"Breast Cancer Trials Committee, Scottish Cancer Trials Office, (MRC) Edinburgh. (1987) Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial.Lancet. 2, 171\u20135.","journal-title":"Lancet."},{"key":"BF01676708_CR19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B. Fisher","year":"1989","unstructured":"Fisher, B., Constantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N.V., Wolmark, N., Wickerham, D.L., Fisher, E.R., Margolese, R., Robidoux, A., Shibata, H., Terz, J., Paterson, A.H.G., Feldman, M.I., Farrar, W., Evans, J., Lickley, H.L., Ketner, M.et al. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-recepter-positive tumors.N. Engl. J. Med. 320, 479\u201384.","journal-title":"N. Engl. J. Med."},{"key":"BF01676708_CR20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","volume":"82","author":"R.R. Love","year":"1990","unstructured":"Love, R.R., Newcomb, P.A., Wiebe, D.A., Surawicz, T.S., Jordan, V.C. and Carbone, P.P. (1990) Lipid and lipoprotein effects of tamoxifen therapy in postmenopausal patients with node-negative breast cancer.J. Natl. Cancer Inst. 82, 1327\u201332.","journal-title":"J. Natl. Cancer Inst."},{"key":"BF01676708_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early breast cancer trialists\u2019 collaborative group","year":"1992","unstructured":"Early breast cancer trialists\u2019 collaborative group (1992) systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.Lancet 339, 1\u201315, 71\u201385.","journal-title":"Lancet"},{"key":"BF01676708_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bmj.303.6800.435","volume":"303","author":"C. C. McDonald","year":"1991","unstructured":"McDonald C. C. and Stewart H.J. (1991) Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial.Br. Med. J. 303, 435\u20137.","journal-title":"Br. Med. J."},{"key":"BF01676708_CR23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/jnci\/85.17.1398","volume":"85","author":"L.E. Rutqvist","year":"1993","unstructured":"Rutqvist, L.E. and Mattsson, A. (1993) Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant therapy.J. Natl. Cancer Inst. 85, 1398\u20131406.","journal-title":"J. Natl. Cancer Inst."},{"key":"BF01676708_CR24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"R.R. Love","year":"1992","unstructured":"Love, R.R., Mazess, R.B., Barden, H.S., Epstein, S., Newcomb, P., Jordan, V.C., Carbone, P.P. and Demets, D. (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.N. Eng. J. Med. 326, 852\u20136.","journal-title":"N. Eng. J. Med."},{"key":"BF01676708_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-8258(91)90330-8","volume":"42","author":"D. Gal","year":"1991","unstructured":"Gal, D., Kopel, S., Bashevkin, M., Lebowicz, J., Lev, R. and Tancer M.L. (1991) Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer-preliminary report.Gynecol. Oncol. 42, 120\u20133.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR26","first-page":"237","volume":"69","author":"M.A. Killackey","year":"1985","unstructured":"Killackey, M.A., Hakes, T.B. and Pierce, V.K. (1985) Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens.Cancer Treat. Rep. 69, 237\u20138.","journal-title":"Cancer Treat. Rep."},{"key":"BF01676708_CR27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(88)92675-X","volume":"3","author":"L. Hardell","year":"1988","unstructured":"Hardell, L. (1988) Tamoxifen as a risk factor for carcinoma of the corpus uteri.Lancet. 3, 563.","journal-title":"Lancet."},{"key":"BF01676708_CR28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0090-8258(90)90371-Q","volume":"37","author":"G. Atlante","year":"1990","unstructured":"Atlante, G., Pozzi, M., Vincenzoni, C. and Vocaturo, G. (1990) Four case reports presenting new acquisitions on the association of breast and endometrial cancer.Gynecol. Oncol. 37, 378\u2013380.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"2","author":"T. Fornander","year":"1989","unstructured":"Fornander, T., Cedermark, B., Mattsson, A., Skoog, L., Theve, T., Askergren, J., Rutquist, L.E., Glas, U., Silfversward, C., Somell, A., Wilking, N. and Hjalmar, M.L. (1989) Adjuvant tamoxifen in early breast breast cancer: occurrence of new primary cancers.Lancet. 2, 117\u201320.","journal-title":"Lancet."},{"key":"BF01676708_CR30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnci\/83.14.1013","volume":"83","author":"M. Andersson","year":"1991","unstructured":"Andersson, M., Storm, H.H. and Mouridsen, H.T. (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer.J. Natl. Cancer Inst. 83, 1013\u201317.","journal-title":"J. Natl. Cancer Inst."},{"key":"BF01676708_CR31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B. Fisher","year":"1994","unstructured":"Fisher, B., Constantino, J.P., Redmond, C.K., Fisher, E.R., Wickerham, D.L., Cronin, W.M. and other NSABP contributors. (1994) Endometrial cancer in tamoxifen-treated beast cancer patients: findings from the National Surgical Adjuant Breast and Bowel Project (NSABP) B-14.J. Natl. Cancer Inst. 86, 527\u201337.","journal-title":"J. Natl. Cancer Inst."},{"key":"BF01676708_CR32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-8258(90)90404-9","volume":"39","author":"J.H. Malfetano","year":"1990","unstructured":"Malfetano, J.H. (1990) Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.Gynecol. Oncol. 39, 82\u20134.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR33","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/jnci\/85.22.1850","volume":"85","author":"T. Fornander","year":"1993","unstructured":"Fornander, T., Hellstrom, A. C. and Moberger, B. (1993) Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.J. Natl. Cancer Inst. 85 1850\u201355.","journal-title":"J. Natl. Cancer Inst."},{"key":"BF01676708_CR34","first-page":"2362","volume":"49","author":"Y. Anzai","year":"1989","unstructured":"Anzai, Y., Holinka, C.F., Kuramoto, H. and Gurpide, E. (1989) Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line).Cancer Res. 49, 2362\u201365.","journal-title":"Cancer Res."},{"key":"BF01676708_CR35","first-page":"1704","volume":"52","author":"Y. Gong","year":"1992","unstructured":"Gong, Y., Ballejo, G., Murphy, L.C. and Murphy, L.J. (1992) Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.Cancer Res. 52, 1704\u201309.","journal-title":"Cancer Res."},{"key":"BF01676708_CR36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0960-0760(92)90356-N","volume":"41","author":"L.J. Murphy","year":"1992","unstructured":"Murphy, L.J., Gong, Y. and Murphy, L. (1992) Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells.J. Steroid Biochem. Molec. Biol. 41, 309\u2013314.","journal-title":"J. Steroid Biochem. Molec. Biol."},{"key":"BF01676708_CR37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(89)91741-8","volume":"1","author":"P. Neven","year":"1989","unstructured":"Neven, P., DeMuylder, X., Van Bellle, Y., Vanderick, G. and DeMuylder, E. (1989) Tamoxifen and the uterus and endometrium (letter).Lancet 1, 375.","journal-title":"Lancet"},{"key":"BF01676708_CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004347-198906000-00005","volume":"81","author":"M.A. Nuovo","year":"1989","unstructured":"Nuovo, M.A., McCaffrey, R.M., Levine, R.U., Barron, B. and Winkler, B. (1989) Endometrial Polyps in postmenopausal patients receiving tamoxifen.Int. J. Gynecol. Pathol. 81, 125\u201331.","journal-title":"Int. J. Gynecol. Pathol."},{"key":"BF01676708_CR39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1471-0528.1990.tb01748.x","volume":"97","author":"D. Corley","year":"1990","unstructured":"Corley, D., Rowe, J., Curtis, M.T., Hogan, W.M., Noumoff, J.S. and LiVolsi, V.A. (1990) Postmenopausal bleeding from unusual endometrial polyps in women receiving tamoxifen therapy, case report.Br. J. Obstet. Gynecol. 97, 190\u201392.","journal-title":"Br. J. Obstet. Gynecol."},{"key":"BF01676708_CR40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0020-7292(91)90767-Y","volume":"36","author":"X. DeMuylder","year":"1991","unstructured":"DeMuylder, X., Neven, P., DeSomer, M., Van Belle, Y., Vanderick, G. and Demuylder, E. (1991) Endometrial lesions in patients undergoing tamoxifen therapy.Int. J. Gynecol. Obstet. 36, 127\u201330.","journal-title":"Int. J. Gynecol. Obstet."},{"key":"BF01676708_CR41","first-page":"119","volume":"158","author":"M.R.W. Ford","year":"1988","unstructured":"Ford, M.R.W., Turner, M.J., Wood, C. and Sautter, W. (1988) Endometriosis developing during tamoxifen therapy.Am. J. Obstet. Gynecol. 158, 119.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF01676708_CR42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0002-9378(92)91854-4","volume":"166","author":"P.V. Dilts","year":"1992","unstructured":"Dilts, P.V. Jr, Hopkins, M.P., Chang, A. and Cody, R.L. (1992) Rapid growth of leiomyoma in patient receiving tamoxifen.Am. J. Obstet. Gynecol. 166, 167\u20138.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF01676708_CR43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1471-0528.1990.tb01748.x","volume":"97","author":"S.S. Cross","year":"1990","unstructured":"Cross, S.S. and Ismail, S.M. (1990) Endometrial hyperplasia in the oophorectomized women receiving tamoxifen therapy, case report.Br. J. Obstet. Gynecol. 97, 190\u20132.","journal-title":"Br. J. Obstet. Gynecol."},{"key":"BF01676708_CR44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/02841869209088912","volume":"31","author":"M. Andersson","year":"1992","unstructured":"Andersson, M., Storm, H.H. and Mouridsen, H.T. (1992) Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer.Acta Oncol. 31, 259\u201363.","journal-title":"Acta Oncol."},{"key":"BF01676708_CR45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/oxfordjournals.aje.a114722","volume":"126","author":"J.A. Schwartzbaum","year":"1987","unstructured":"Schwartzbaum, J.A., Hulka, B.S., Fowler, W.C. Jr., Kaufman, D.G. and Hoberman, D. (1987) The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer.Am. J. Epidemiol. 126, 851\u201360.","journal-title":"Am. J. Epidemiol."},{"key":"BF01676708_CR46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/014107688407700704","volume":"77","author":"M.P. Vessey","year":"1984","unstructured":"Vessey, M.P. (1984) Exogenous hormones in the aetiology of cancer in women.J. R. Soc. Med. 77, 542\u20139.","journal-title":"J. R. Soc. Med."},{"key":"BF01676708_CR47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","volume":"11","author":"U. Magriples","year":"1993","unstructured":"Magriples, U., Naftolin, F., Schwartz, P.E. and Carcangiu, M.L. (1993) High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.J. Clin. Oncol. 11, 485\u201390.","journal-title":"J. Clin. Oncol."},{"key":"BF01676708_CR48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/gyno.1994.1271","volume":"55","author":"R.R. Barakat","year":"1994","unstructured":"Barakat, R.R., Wong, G., Curtin, J.P., Vlamis, V. and Hoskins, W.J. (1994) Tamoxifen use in breast patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.Gynecol. Oncol. 55, 164\u20138.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","volume":"343","author":"F.E. Leeuwen van","year":"1994","unstructured":"van Leeuwen, F.E., Bernraadt, J., Coebergh, J.W.W., Kiementy, C.A., Gimbrere, C.H., Otter, R., Schouten, L.J., Damhuis, R.A., Bontenbal, M., Diepenhorst, F.W., van den Belt-Dusebout, A.W. and van Tinteren, H. (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer.Lancet. 343, 448\u2013452.","journal-title":"Lancet."},{"key":"BF01676708_CR50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(88)92675-X","volume":"3","author":"L. Hardell","year":"1988","unstructured":"Hardell, L. (1988) Tamoxifen as a risk factor for carcinoma of corpus uteri.Lancet,3, 563.","journal-title":"Lancet"},{"key":"BF01676708_CR51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1993.1118","volume":"49","author":"M.M. Altaras","year":"1993","unstructured":"Altaras, M.M., Aviram, R., Cohen, I., Cordoba, M., Yarkoni, S. and Beyth, Y. (1993) Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas.Gynecol. Oncol. 49, 255\u20138.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/gyno.1993.1314","volume":"51","author":"MR. Clarke","year":"1993","unstructured":"Clarke, MR. (1993) Uterine malignant mixed mullerian tumor in a patient on long-term tamoxifen therapy for breast cancer.Gynecol. Oncol. 51, 411\u20135.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR53","first-page":"809","volume":"160","author":"C.A. Hulka","year":"1993","unstructured":"Hulka, C.A. and Hall, D.A. (1993) Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation.Am. J. Radiol. 160, 809\u201312.","journal-title":"Am. J. Radiol."},{"key":"BF01676708_CR54","first-page":"660","volume":"81","author":"E. Lahti","year":"1993","unstructured":"Lahti, E., Blanco, G., Kauppila, A., Apaja-Sarkkinen, M., Taskinen, P.J. and Laatikainen, T. (1993) Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.Obstet. Gynecol. 81, 660\u20134.","journal-title":"Obstet. Gynecol."},{"key":"BF01676708_CR55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7863\/jum.1993.12.5.275","volume":"5","author":"I. Cohen","year":"1993","unstructured":"Cohen, I., Rosen, D.J.D., Tepper, R., Cordoba, M., Shapira, Y., Altaras, M., Yigael, D. and Beyth, Y. (1993) Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen.J. Ultrasound. Med. 5, 275\u201380.","journal-title":"J. Ultrasound. Med."},{"key":"BF01676708_CR56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/gyno.1994.1029","volume":"52","author":"I. Cohen","year":"1994","unstructured":"Cohen, I., Rosen, D.J.D., Shapira, J., Cordoba, M., Gilboa, S., Altaras, M., Yigael, D. and Beyth Y. (1994) Endometrial changes with tamoxifen: comparison between tamoxifen treated and nontreated asymptomatic post menopausal breast cancer patients.Gynecol. Oncol. 52, 185\u201390.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9378(94)70209-8","volume":"170","author":"S.R. Goldstein","year":"1994","unstructured":"Goldstein, S.R. (1994) Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.Am. J. Obstet. Gynecol. 170, 447\u2013451.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF01676708_CR58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/gyno.1994.1263","volume":"55","author":"I. Cohen","year":"1994","unstructured":"Cohen, I., Tepper, R., Rosen, D., Shapira, J., Cordoba, M., Dror, Y., Altaras, M. and Beyth, Y. (1994) Continuous tamoxifen treatment in asymptomatic post menopausal breast cancer patients does not cause aggravation of endometrial pathologies.Gynecol. Oncol. 55, 138\u201343.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/joe.0.0700421","volume":"70","author":"G.V. Groom","year":"1976","unstructured":"Groom, G.V. and Griffiths, K. (1976) Effect of the antiestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, estradiol, and progesterone in normal pre-menopausal women.J. Endocrinol. 70, 421\u20138.","journal-title":"J. Endocrinol."},{"key":"BF01676708_CR60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI109475","volume":"64","author":"B.M. Sherman","year":"1979","unstructured":"Sherman, B.M., Chapler, F.K., Crickard, K. and Wycoff, D. (1979) Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.J. Clin. Invest. 64, 398\u2013404.","journal-title":"J. Clin. Invest."},{"key":"BF01676708_CR61","first-page":"779","volume":"64","author":"A. Manni","year":"1980","unstructured":"Manni, A. and Pearson, O.H. (1980) Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function.Cancer Treat. Rep. 64, 779\u201385.","journal-title":"Cancer Treat. Rep."},{"key":"BF01676708_CR62","first-page":"1026","volume":"48","author":"P.M. Radvin","year":"1988","unstructured":"Radvin, P.M., Fritz, N.F., Tormey, D.C. and Jordan, V.C. (1988), Endocrine status of premenopausal node positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.Cancer Res. 48, 1026\u201329.","journal-title":"Cancer Res."},{"key":"BF01676708_CR63","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/0140-6736(91)93096-R","volume":"337","author":"D.V. Spicer","year":"1991","unstructured":"Spicer, D.V., Pike, M.C. and Henderson, B.E. (1991) Ovarian cancer and long-term tamoxifen in premenopausal women.The Lancet. 337, 1414.","journal-title":"The Lancet."},{"key":"BF01676708_CR64","first-page":"398","volume":"61","author":"I.E. Messinis","year":"1979","unstructured":"Messinis, I.E. and Nillius, S.J. (1979) Comparison between tamoxifen and clomiphene for induction of ovulation.Acta Obstet. Gynecol. Scand. 61, 398\u2013404.","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"BF01676708_CR65","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/oxfordjournals.humrep.a138217","volume":"8","author":"A.S. Whittemore","year":"1993","unstructured":"Whittemore, A.S. (1993) Fertility drugs and risk of ovarian cancer.Human Reprod. 8, 999\u20131000.","journal-title":"Human Reprod."},{"key":"BF01676708_CR66","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0002-9378(92)91348-E","volume":"166","author":"G.L. Goldberg","year":"1992","unstructured":"Goldberg, G.L. and Runowicz, C.D. (1992) Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation-is there a link?Am. J. Obstet. Gynecol. 166, 853\u20134.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF01676708_CR67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0015-0282(16)55688-X","volume":"59","author":"R.L. Barbieri","year":"1993","unstructured":"Barbieri, R.L., Ferraci, A.L., Droesch, J.N. and Rachelson, B.L. (1993) Ovarian torsion in a premenopausal women treated with tamoxifen for breast cancer.Fertil. Steril. 59, 459\u201360.","journal-title":"Fertil. Steril."},{"key":"BF01676708_CR68","first-page":"299","volume":"35","author":"C.J. Jolles","year":"1990","unstructured":"Jolles, C.J., Smotkin, D., Ford, K.L. and Jones, K.P. (1990) Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman.J. Reprod. Med. 35, 299\u2013300.","journal-title":"J. Reprod. Med."},{"key":"BF01676708_CR69","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1994.116","volume":"69","author":"I. Cohen","year":"1994","unstructured":"Cohen, I. Rosen, D.J.D., Altaras, M., Beyth, Y., Shapira, J. and Yigael, D. (1994) Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.Br. J. Cancer. 69, 620\u201321.","journal-title":"Br. J. Cancer."},{"key":"BF01676708_CR70","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/oxfordjournals.humrep.a138723","volume":"9","author":"A. Shulman","year":"1994","unstructured":"Shulman, A., Cohen, I., Altaras, M., Maymon, R., Ben-Nun, I., Tepper, R. and Beyth, Y. (1994) Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer.Human Reprod. 9, 1427\u201329.","journal-title":"Human Reprod."},{"key":"BF01676708_CR71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000225571","volume":"38","author":"F. Boccardo","year":"1981","unstructured":"Boccardo, F., Bruzzi, P., Rubagotti, A., Nicolo, G. and Rosso, R. (1981) Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients.Oncology 38, 281\u20135.","journal-title":"Oncology"},{"key":"BF01676708_CR72","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.1.6072.1351-e","volume":"1","author":"E. Ferrazzi","year":"1977","unstructured":"Ferrazzi, E., Gartei, G., Mattarazzo, R. and Fiorentino, M. (1977) Oestrogen-like effect of tamoxifen on vaginal epithelium.Br. Med. J. 1, 1351\u201352.","journal-title":"Br. Med. J."},{"key":"BF01676708_CR73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/ageing\/20.1.52","volume":"20","author":"A. Miodrag","year":"1991","unstructured":"Miodrag, A., Ekelund, P., Burton, R. and Castleden, C.M. (1991) Tamoxifen and partial oestrogen agonist in post menopausal women. Age and aging.20, 52\u20134.","journal-title":"Age and aging."},{"key":"BF01676708_CR74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2303.1990.tb00359.x","volume":"1","author":"T.P. Eells","year":"1990","unstructured":"Eells, T.P., Alpern, H.D., Grzywacz, C., MacMillan, R.W. and Olson, JE. (1990) The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women.Cytopathology,1, 263\u20138.","journal-title":"Cytopathology"},{"key":"BF01676708_CR75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-8258(90)90360-W","volume":"37","author":"G. Scambia","year":"1990","unstructured":"Scambia, G., Benedetti Panici, P., Baiocchi, G., Battaglia, F., Ferrandina, G., Greggi, S. and Mancuso, S. (1990)Gynecol. Oncol. 37, 323\u20136.","journal-title":"Gynecol. Oncol."},{"key":"BF01676708_CR76","first-page":"1750","volume":"40","author":"M. Namer","year":"1980","unstructured":"Namer, M., Lalanne, C. and Baulieu, E.E. (1980) Increase of progesterone recetor by tamoxifen as a hormonal challenge test in breast cancer.Cancer Res. 40, 1750\u201352.","journal-title":"Cancer Res."},{"key":"BF01676708_CR77","first-page":"1140","volume":"41","author":"R. Mortel","year":"1981","unstructured":"Mortel, R., Levy, C., Wolff, J.P., Nicholas, J.C., Robel, P. and Baulieu, E.E. (1981) Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen.Cancer Res. 41, 1140\u20137.","journal-title":"Cancer Res."},{"key":"BF01676708_CR78","first-page":"6848","volume":"52","author":"J.Y. Hwang","year":"1992","unstructured":"Hwang, J.Y., Lin, B.Y., Tang, F.M. and Yu, W.C.Y. (1992) Tamoxifen stimulates human Papillomavirus type 16 gene expression and cell proliferation in a cervical cancer line.Cancer Res. 52, 6848\u201352.","journal-title":"Cancer Res."},{"key":"BF01676708_CR79","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/gyno.1994.1069","volume":"52","author":"H.E. Sonnendecker","year":"1994","unstructured":"Sonnendecker, H.E., Cooper, K. and Kalian, K.N. (1994) Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma.Gynecol. Oncol. 52, 402\u201307.","journal-title":"Gynecol. Oncol."}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01676708.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01676708\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01676708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T13:58:18Z","timestamp":1557237498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01676708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF01676708"],"URL":"https:\/\/doi.org\/10.1007\/bf01676708","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}